Immunogenicity 11029
Sample ID
3678
Response
Negative
Tumor Type
Melanoma
Gene Symbol
RAD54B
Transcript ID
None
HLA INFO
C*14:02
TCR INFO
No TCR info found!
Full length protein sequence (726 aa)
MICGK
1
EIEVM
6
GVISP
11
DDFSS
16
GRCFQ
21
LGGGS
26
TAISH
31
SSQVA
36
RKCFS
41
NPFKS
46
VCKPS
51
SKENR
56
QNDFQ
61
NCKPR
66
HDPYT
71
PNSLV
76
MPRPD
81
KNHQW
86
VFNKN
91
CFPLV
96
DVVID
101
PYLVY
106
HLRPH
111
QKEGI
116
IFLYE
121
CVMGM
126
RMNGR
131
CGAIL
136
ADEMG
141
LGKTL
146
QCISL
151
IWTLQ
156
CQGPY
161
GGKPV
166
IKKTL
171
IVTPG
176
SLVNN
181
WKKEF
186
QKWLG
191
SERIK
196
IFTVD
201
QDHKV
206
EEFIK
211
SIFYS
216
VLIIS
221
YEMLL
226
RSLDQ
231
IKNIK
236
FDLLI
241
CDEGH
246
RLKNS
251
AIKTT
256
TALIS
261
LSCEK
266
RIILT
271
GTPIQ
276
NDLQE
281
FFALI
286
DFVNP
291
GILGS
296
LSSYR
301
KIYEE
306
PIILS
311
REPSA
316
SEEEK
321
ELGER
326
RAAEL
331
TCLTG
336
LFILR
341
RTQEI
346
INKYL
351
PPKIE
356
NVVFC
361
RPGAL
366
QIELY
371
RKLLN
376
SQVVR
381
FCLQG
386
LLENS
391
PHLIC
396
IGALK
401
KLCNH
406
PCLLF
411
NSIKE
416
KECSS
421
TCDKN
426
EEKSL
431
YKGLL
436
SVFPA
441
DYNPL
446
LFTEK
451
ESGKL
456
QVLSK
461
LLAVI
466
HELRP
471
TEKVV
476
LVSNY
481
TQTLN
486
ILQEV
491
CKRHG
496
YAYTR
501
LDGQT
506
PISQR
511
QQIVD
516
GFNSQ
521
HSSFF
526
IFLLS
531
SKAGG
536
VGLNL
541
IGGSH
546
LILYD
551
IDWNP
556
ATDIQ
561
AMSRV
566
WRDGQ
571
KYPVH
576
IYRLL
581
TTGTI
586
EEKIY
591
QRQIS
596
KQGLC
601
GAVVD
606
LTKTS
611
EHIQF
616
SVEEL
621
KNLFT
626
LHESS
631
DCVTH
636
DLLDC
641
ECTGE
646
EVHTG
651
DSLEK
656
FIVSR
661
DCQLG
666
PHHQK
671
SNSLK
676
PLSMS
681
QLKQW
686
KHFSG
691
DHLNL
696
TDPFL
701
ERITE
706
NVSFI
711
FQNIT
716
TQATG
721
T
726
Mutation Information
DNA mutation:
None
Peptide Range:
66 ~ 90
Mut AA position:
78 (13 in Wild Type peptide)
Alignment
Wild Type:
"NCKPRHDPYTPNSLVMPRPDKNHQW
||||||||||||.||||||||||||
Mutant:
NCKPRHDPYTPNFLVMPRPDKNHQW"
Clin Cancer Res, 2017
Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 ExpressionGene Name (from Reference) RAD54B
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
TILs
APC
Type
autologous DCs
Assay
ELISPOT assay